NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.07 +0.07 (+0.09%) GOLD FUTURES
2,332.10 +21.10 (+0.91%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,169.96 -2,116.03 (-4.38%)
Option NV (OINA.F)
| Previous close | 0.0100 |
| Open | 0.0100 |
| Bid | 0.0002 x 5744700 |
| Ask | 0.0164 x 4402200 |
| Day's range | 0.0100 - 0.0100 |
| 52-week range | 0.0036 - 0.0194 |
| Volume | |
| Avg. volume | 1,277 |
| Market cap | 25.923M |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Prem Watsa's Strategic Move: A Closer Look at the Crescent Capital BDC Inc Trade
On April 8, 2024, Prem Watsa (Trades, Portfolio)'s firm, Fairfax Financial Holdings, made a notable adjustment to its investment portfolio by reducing its stake in Crescent Capital BDC Inc (NASDAQ:CCAP). This move had a -0.31% impact on the portfolio, leaving the firm with a total of 1,824,805 shares in CCAP, which now represents 2.13% of the portfolio and 4.90% of the firm's holdings in the traded stock. Prem Watsa (Trades, Portfolio), the founder and leader of Fairfax Financial Holdings, is a renowned figure in the investment world.
- Zacks
Crescent Capital BDC (CCAP) Stock Moves -1.05%: What You Should Know
Crescent Capital BDC (CCAP) closed at $17 in the latest trading session, marking a -1.05% move from the prior day.
- Zacks
Is It Worth Investing in Crescent Capital BDC (CCAP) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Crescent Capital BDC (CCAP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
